WCG Expands Board of Directors with Three Distinguished Appointments

Key Facts

WCG, the global leader in providing solutions that improve and accelerate clinical research, is pleased to announce the appointment of three industry leaders to its board of directors.
The strategic additions of Ken Getz, Bob Hugin, and Dr. Amrit Ray bring a wealth of experience and expertise to guide the continued growth and value creation at WCG.
Along with his board director experience at companies such as Fortrea, Ultragenyx, and Press Ganey, Dr. Ray is a trustee at The Hastings Center for bioethics and serves on the steering group of the Good Clinical Trials Collaborative, reflecting his commitment to patient advocacy and advancing global healthcare.
These additions to the board of directors will further strengthen WCG's position as a thought leader and trusted partner in clinical research.